GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Enzymatica AB (publ) ENZY.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.40

-2.04%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Enzymatica AB (publ) annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 53.9mSEK 45.6mSEK 50.9mSEK 48.9mSEK 57.2m
Operating income−SEK 52.2m−SEK 52.1m−SEK 47.6m−SEK 67.8m−SEK 44.8m
Net income−SEK 51.9m−SEK 53.2m−SEK 49.7m−SEK 68.7m−SEK 45.4m
Free cash flow−SEK 41.2m−SEK 60.9m−SEK 41.0m−SEK 68.3m−SEK 42.0m
Total assetsSEK 142.0mSEK 195.2mSEK 125.9mSEK 174.4mSEK 157.0m
Shareholders' equitySEK 124.2mSEK 176.4mSEK 76.6mSEK 126.3mSEK 125.0m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.